|
|
|
|
Published online before print
February 22, 2008, 10.1101/gr.7187808 Genome Res. 18:622-630, 2008 ©2008 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/08 $5.00 OPEN ACCESS ARTICLE
Methods Large-scale screening for novel low-affinity extracellular protein interactions1 Cell Surface Signalling Laboratory, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, United Kingdom; 2 Pfam Group, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1HH, United Kingdom
Extracellular protein–protein interactions are essential for both intercellular communication and cohesion within multicellular organisms. Approximately a fifth of human genes encode membrane-tethered or secreted proteins, but they are largely absent from recent large-scale protein interaction datasets, making current interaction networks biased and incomplete. This discrepancy is due to the unsuitability of popular high-throughput methods to detect extracellular interactions because of the biochemical intractability of membrane proteins and their interactions. For example, cell surface proteins contain insoluble hydrophobic transmembrane regions, and their extracellular interactions are often highly transient, having half-lives of less than a second. To detect transient extracellular interactions on a large scale, we developed AVEXIS (avidity-based extracellular interaction screen), a high-throughput assay that overcomes these technical issues and can detect very transient interactions (half-lives 0.1 sec) with a low false-positive rate. We used it to systematically screen for receptor–ligand pairs within the zebrafish immunoglobulin superfamily and identified novel ligands for both well-known and orphan receptors. Genes encoding receptor–ligand pairs were often clustered phylogenetically and expressed in the same or adjacent tissues, immediately implying their involvement in similar biological processes. Using AVEXIS, we have determined the first systematic low–affinity extracellular protein interaction network, supported by independent biological data. This technique will now allow large-scale extracellular protein interaction mapping in a broad range of experimental contexts.
Extracellular protein interactions such as those made between secreted and membrane-tethered proteins are important for diverse cellular behaviors, such as initiating differentiation pathways, directing migration and pathfinding routes, and mediating intricate recognition processes. Approximately a fifth of human genes encode extracellular and membrane-associated proteins, but despite their importance and abundance, they are significantly underrepresented in recent large-scale protein interaction datasets (Futschik et al. 2007
Existing methods to directly detect extracellular transient interactions often rely on experimentally increasing the overall avidity of the interaction by multimerizing a soluble recombinant protein, mirroring the way these interactions occur in vivo through arrayed proteins on apposing membranes. These methods include oriented display around microbeads (Wright et al. 2000 To address the need for a high-throughput technique that can detect low-affinity extracellular protein interactions, we have developed a novel assay termed AVEXIS (avidity-based extracellular interaction screen) and used it to identify novel extracellular receptor–ligand pairs within the zebrafish immunoglobulin superfamily (IgSF). Independent support for identified interactions was provided by quantifying interaction strengths, performing a phylogenetic analysis, and showing that genes encoding interacting pairs were expressed in either the same or adjacent tissues.
AVEXIS can specifically detect low-affinity extracellular protein interactions with a low false-positive rate To retain the extracellular binding function while removing the insoluble transmembrane region, the entire ectodomains of cell surface proteins were produced as soluble recombinant proteins in mammalian cells. Ectodomains were expressed in two different forms: a monomeric biotinylated "bait," which could be captured on streptavidin-coated microtiter plates, and a pentamerized "prey" tagged with β-lactamase to allow detection. The prey pentamers were produced by C-terminally tagging proteins with a coiled-coil sequence from the rat cartilage oligomeric matrix protein (Tomschy et al. 1996
To determine the false-positive and -negative rates of AVEXIS, a small screen was performed using eight proteins from the SLAM/CD2 subfamily of the human IgSF within which there are quantified positive hetero- and homophilic low-affinity interactions and also, importantly, published negative interactions. This set represents a "gold standard" of positive and negative interactions for assay benchmarking and validation. A prey activity threshold was selected which was able to detect the 8 µM CD244–CD48 interaction (Brown et al. 1998
A large systematic protein interaction screen identifies novel extracellular receptor–ligand pairs To identify novel extracellular receptor–ligand pairs, a protein library containing the entire ectodomains of 110 proteins, mainly from the zebrafish IgSF, was expressed in mammalian cells as both bait and prey molecules, and their activities normalized (Table S1). This protein family was chosen since they are known to form receptor–ligand pairs between themselves (Barclay 2003 Within our interaction network we found that approximately half of the proteins had multiple binding partners, suggesting competition between potential ligands in tissues where they are co-expressed. The paucity of interaction data for zebrafish proteins made the identification of entirely novel interactions and the assessment of a false-negative rate very difficult. For proteins where a clear mammalian ortholog could be identified (protein sequence identity > 40%, see Table S1) we were able to detect within our network some interactions previously reported in mammals (Fig. 2).
Novel interactions identified in the screen included proteins with no known extracellular ligand (orphan receptors). This included a subnetwork involving the Mpzl2 protein, a gene expressed during mouse thymus development (Guttinger et al. 1998
AVEXIS can detect interactions with a half-life
Extracellular receptor–ligand pairs are enriched for paralogs Large-scale proteomics experiments in yeast, which mainly detect stable cytoplasmic complexes, are enriched for interactions between paralogous proteins (Ispolatov et al. 2005
Genes encoding interacting proteins are often expressed in the same or neighboring tissues To mediate adhesion or initiate signaling, membrane proteins are likely to be expressed on the surface of the same or neighboring cells at the same stage of development. To determine which receptor–ligand pairs are co-expressed and also to provide clues for the in vivo function of identified interactions, the transcriptional expression patterns for all genes encoding interacting proteins were determined by whole-mount in situ hybridization at several stages during the first 48 h of zebrafish development. Of the 19 genes in our interaction network, 18 were expressed during the first 24 h and all by 48 h, suggesting that these genes have roles during the earliest stages of vertebrate development. IgSF-domain–containing proteins are known to have diverse functions (Rougon and Hobert 2003
We have described the development of AVEXIS, an assay that overcomes the technical difficulties associated with detecting extracellular protein interactions and can be used in both small and larger—including genome-wide—interaction screens. The assay has several features that will allow it to be widely useful. First, it is not system-specific and can therefore be applied to screen for interactions between extracellular proteins from most metazoans. In our study, for example, we have used both human and zebrafish proteins. Second, we have demonstrated that AVEXIS is suitable for systematic large-scale screens and have provided a full screening assessment showing that it has a very low false-positive rate. Thirdly, we have shown that it can detect extremely low-affinity interactions, certainly at or below half-lives of a tenth of a second. Finally, we have provided independent biological support for several of the interactions identified in our screen that suggest they occur in vivo. Taken together, AVEXIS is therefore a versatile technique to detect and study low-affinity extracellular interactions in a high-throughput format.
The number of identified protein–protein interactions has increased rapidly with the use of high-throughput interaction assays, with the yeast-two-hybrid (Y2H) and biochemical purification "TAP-tagging" techniques being especially successful. Due to the heterogeneity of protein–protein interactions and the practical limitations of large-scale screening, each assay must inevitably accept a certain rate of false positives and negatives. For example, the Y2H and TAP-tagging methods are unsuitable to detect transient extracellular interactions because they do not add essential post-translational modifications (Y2H) or the stringent wash steps preclude detection of weak interactions. These limitations are well appreciated and have led to the development of other scalable assays to detect specialized classes of protein interactions unsuited to these methods; for example, the split-ubiquitin system to detect interactions between membrane proteins embedded within the same membrane (Stagljar et al. 1998 By using AVEXIS, we have described the first low-affinity extracellular protein interaction network. We have shown that many cell surface and secreted proteins have more than one binding partner. Given that we have screened only around a fifth of the total zebrafish IgSF family and a fraction of the total extracellular proteome, it is likely that extracellular interaction networks will be highly connected, as described for intracellular networks. Also similar to other protein interaction networks, we observed an enrichment of paralogous pairs between interacting partners, which suggests gene duplication as a common mechanism for the evolution of novel interactions.
Within the zebrafish IgSF, we have identified interactions between previously uncharacterized proteins. For example, we have discovered a subnetwork of three proteins: Mpzl2, Mpzl3, and Cssl:d179, which are all localized to the cell surface of the developing pronephric duct epithelium and epidermis, suggesting a role in cellular adhesion. The interaction strength between Mpzl3 and Cssl:d179 is one of the weakest that we measured (t1/2
Using AVEXIS, we have also discovered novel interactions for well-studied proteins. We have demonstrated that the full-length muscle-specific kinase (Musk FL) isoform (Zhang et al. 2004
Consistent with the Fgfrl1a–Fgfr11b interaction identified in our screen, a functional study of both genes in zebrafish points toward their involvement in the same biological process: knocking down either gene resulted in the same striking phenotype, a loss of the ceratobranchial arches in the gill cartilage (Hall et al. 2006 Protein–protein interactions, although they are likely to have evolved using similar processes, are mechanistically very diverse, varying in both affinity and surrounding subcellular environment. It therefore seems unlikely that any one particular technique will be suitable to detect all classes of protein–protein interaction; rather, techniques tailored to detect particular classes will be necessary. The use of AVEXIS will now make the identification of low-affinity extracellular interactions possible on a large scale and contribute to the defining of a complete and accurate protein interaction network. AVEXIS is not organism specific and can therefore be used in many contexts, including extracellular host–pathogen interaction mapping to identify pathogen receptors. Indeed, the interaction between pathogen proteins and their host cell surface receptors is often the initiating event during infections. Since extracellular proteins are readily accessible to systemically delivered drugs, AVEXIS can therefore be used to identify novel therapeutic opportunities to target both genetic and infectious diseases.
Sources of zebrafish genes and ectodomain protein expression library A comprehensive list of all genes used in this study is provided in Table S1. Zebrafish genes encoding immunoglobulin superfamily (IgSF) domains were obtained from three sources: (1) "known" genes already deposited in gene databases (32 genes) and amplified by RT-PCR from mixed-stage zebrafish cDNA; (2) zebrafish IMAGE clones (85 genes) that were predicted to encode IgSF domains and a complete signal peptide were identified from EST databases by TBLASTN searches using all human and mouse IgSF-domain-encoding protein sequences; and (3) novel genes identified from the zebrafish genome sequence (32 genes). The complete extracellular region and signal peptide were obtained by both 5' and 3' RACE procedures. Bait and prey ectodomain expression clones were made for 125 genes; 110 (88%) produced sufficient protein (>0.1 µg/mL). All clones were fully sequenced.
Mammalian expression system
Bait protein expression
Prey protein constructs
Bait and prey protein normalization Biotinylated bait protein concentrations were determined by ELISA using streptavidin-coated plates (Nunc). Protein activities were measured with a mouse anti-rat Cd4 antibody (OX68, Serotec) followed by incubation with an anti-mouse alkaline phosphatase secondary and detected with p-nitrophenyl phosphate. Biotinylated protein concentrations were normalized by either concentrating using spin concentrators (Vivascience, 10 k MWCO) or diluting with conditioned tissue culture supernatant or PBS containing 0.2% BSA; 50 µL of a 10–100 nM biotinylated protein concentration was found to be sufficient to saturate the available streptavidin on the plates. Prey protein solutions used for interaction screening were normalized using the beta-lactamase enzymatic activity. One unit of activity was defined as the amount of prey construct required to turnover 1 nmol of nitrocefin (Calbiochem) in 1 min at room temperature. Twenty microliters of serial dilutions of prey supernatants were incubated with 60 µL of 250 µg/mL nitrocefin at room temperature for 20 min, and nitrocefin turnover was quantitated by measuring the absorbance at 485 nm. Prey proteins were normalized by concentrating with 20 k MWCO spin concentrators or diluting in the same manner as the bait proteins to within an order of magnitude, with a minimum threshold of 50 units/mL.
AVEXIS screening Arrayed biotinylated bait proteins were captured on streptavidin-coated plates as described above by incubating 50 µL of normalized bait proteins for 1 h at room temperature. Plates were washed three times with PBS, and each plate was probed with 50 µL/well of a normalized beta-lactamase-tagged prey protein and incubated at room temperature for 1 h. Plates were washed twice with PBS containing 0.05% Tween-20 and then twice with PBS alone before adding 50 µL of 150 µg/mL nitrocefin dissolved according to the manufacturers instructions. Plates were incubated at room temperature for 3 to 4 h and then overnight at 4°C. Interactions were identified by taking absorbance readings at 485 nm and positive interactions called as having a plate Z-score of >6; that is, the positive wells were >6 standard deviations above the plate mean. Relying on absorbance readings alone, however, resulted in a significant number of technical false positives, since wells with high absorbance readings sometimes did not show visible substrate turnover; this was attributed to unavoidable imperfections/scratches on the microtiter plates or precipitated nitrocefin. Technical false positives were eliminated by photographing the screening plates and verifying substrate turnover in true-positive wells. A total of 110 proteins were used for the interaction screening, representing a total of (1102 + 110)/2 = 6105 unique interactions screened. The majority of the library was tested in both bait–prey orientations (7292 interactions), although a proportion (2459, including all homophilic interactions) was only screened in one bait–prey orientation, making a total of 9751 tested interactions. Proteins which showed positive hits were then re-expressed and tested in a second, independent "validation" screen using both bait–prey orientations in the same matrix-style fashion. Interactions were classified from A to J according to the criteria listed in Table S2. One prey construct, Cssl:d805, showed positive interactions with >50% of bait proteins and was therefore excluded from further analysis.
AVEXIS validation
The full-length coding regions of the eight members of the human CD2 and SLAM family members used for false-positive and -negative rate determination were provided by the Sanger Institute cORF cloning group. These cDNAs were cloned from either existing MGC clones or amplified from mixed-tissue human cDNA essentially as described (Collins et al. 2004
Protein purification and gel filtration for SPR studies
Kinetic analysis of interactions using SPR
Phylogenetic analysis
Zebrafish husbandry
In situ hybridization
Antibodies and immunohistochemistry
We thank A. Neil Barclay and Marion H. Brown for reagents; the Sanger Institute cORF program and Nick Bockett for gene cloning; and David Goulding for help with confocal microscopy. This work was supported by the Wellcome Trust and a Marie Curie and Sanger postdoctoral fellowship to C.S.
3 Corresponding author.
E-mail gw2{at}sanger.ac.uk; fax 44-1223-496802. [Supplemental material is available online at www.genome.org. The sequences of all the genes cloned for this study have been submitted to GenBank, and their accession numbers are listed in Supplemental Table S1. All protein–protein interaction data have been submitted to the IntAct database under accession nos. EBI-1578837 and EBI-1578841 for AVEXIS and SPR validation data, respectively.] Article published online before print. Article and publication date are at http://www.genome.org/cgi/doi/10.1101/gr.7187808.
Aricescu, A.R., Hon, W.C., Siebold, C., Lu, W., van der Merwe, P.A., and Jones, E.Y. 2006. Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion. EMBO J. 25: 701–712.[CrossRef][Medline] Barclay, A.N. 2003. Membrane proteins with immunoglobulin-like domains—A master superfamily of interaction molecules. Semin. Immunol. 15: 215–223.[CrossRef][Medline] Brown, M.H. and Barclay, A.N. 1994. Expression of immunoglobulin and scavenger receptor superfamily domains as chimeric proteins with domains 3 and 4 of CD4 for ligand analysis. Protein Eng. 7: 515–521. Brown, M.H., Boles, K., van der Merwe, P.A., Kumar, V., Mathew, P.A., and Barclay, A.N. 1998. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188: 2083–2090. Clark, H.F., Gurney, A.L., Abaya, E., Baker, K., Baldwin, D., Brush, J., Chen, J., Chow, B., Chui, C., Crowley, C., et al. 2003. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: A bioinformatics assessment. Genome Res. 13: 2265–2270. Collins, J.E., Wright, C.L., Edwards, C.A., Davis, M.P., Grinham, J.A., Cole, C.G., Goward, M.E., Aguado, B., Mallya, M., Mokrab, Y., et al. 2004. A genome annotation-driven approach to cloning the human ORFeome. Genome Biol. 5: R84. doi: 10.1186/gb-2004-5-10-r84.[CrossRef][Medline] DeChiara, T.M., Bowen, D.C., Valenzuela, D.M., Simmons, M.V., Poueymirou, W.T., Thomas, S., Kinetz, E., Compton, D.L., Rojas, E., Park, J.S., et al. 1996. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85: 501–512.[CrossRef][Medline] Durocher, Y., Perret, S., and Kamen, A. 2002. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30: e9; http://nar.oxfordjournals.org/cgi/content/full/30/2/e9. Falco, M., Marcenaro, E., Romeo, E., Bellora, F., Marras, D., Vely, F., Ferracci, G., Moretta, L., Moretta, A., and Bottino, C. 2004. Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. Eur. J. Immunol. 34: 1663–1672.[CrossRef][Medline] Felsenstein, J. 2005. PHYLIP (Phylogeny Inference Package), version 3.6 Distributed by the author, Department of Genome Sciences, University of Washington, Seattle, WA. Flaig, R.M., Stark, S., and Watzl, C. 2004. Cutting edge: NTB-A activates NK cells via homophilic interaction. J. Immunol. 172: 6524–6527. Futschik, M.E., Chaurasia, G., and Herzel, H. 2007. Comparison of human protein–protein interaction maps. Bioinformatics 23: 605–611. George, R.A. and Heringa, J. 2002. An analysis of protein domain linkers: Their classification and role in protein folding. Protein Eng. 15: 871–879. Gill, S.C. and von Hippel, P.H. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182: 319–326.[CrossRef][Medline] Gonzalez, L.C., Loyet, K.M., Calemine-Fenaux, J., Chauhan, V., Wranik, B., Ouyang, W., and Eaton, D.L. 2005. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. 102: 1116–1121. Guttinger, M., Sutti, F., Panigada, M., Porcellini, S., Merati, B., Mariani, M., Teesalu, T., Consalez, G.G., and Grassi, F. 1998. Epithelial V-like antigen (EVA), a novel member of the immunoglobulin superfamily, expressed in embryonic epithelia with a potential role as homotypic adhesion molecule in thymus histogenesis. J. Cell Biol. 141: 1061–1071. Haddon, C. and Lewis, J. 1996. Early ear development in the embryo of the zebrafish, Danio rerio. J. Comp. Neurol. 365: 113–128.[CrossRef][Medline] Hall, C., Flores, M.V., Murison, G., Crosier, K., and Crosier, P. 2006. An essential role for zebrafish Fgfrl1 during gill cartilage development. Mech. Dev. 123: 925–940.[CrossRef][Medline] Holler, N., Kataoka, T., Bodmer, J.L., Romero, P., Romero, J., Deperthes, D., Engel, J., Tschopp, J., and Schneider, P. 2000. Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. J. Immunol. Methods 237: 159–173.[CrossRef][Medline] Ispolatov, I., Yuryev, A., Mazo, I., and Maslov, S. 2005. Binding properties and evolution of homodimers in protein–protein interaction networks. Nucleic Acids Res. 33: 3629–3635. Katoh, K., Kuma, K., Toh, H., and Miyata, T. 2005. MAFFT version 5: Improvement in accuracy of multiple sequence alignment. Nucleic Acids Res. 33: 511–518. Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., and Schilling, T.F. 1995. Stages of embryonic development of the zebrafish. Dev. Dyn. 203: 253–310.[Medline] Kumaresan, P.R., Lai, W.C., Chuang, S.S., Bennett, M., and Mathew, P.A. 2002. CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Mol. Immunol. 39: 1–8.[CrossRef][Medline] Letarte, M., Voulgaraki, D., Hatherley, D., Foster-Cuevas, M., Saunders, N.J., and Barclay, A.N. 2005. Analysis of leukocyte membrane protein interactions using protein microarrays. BMC Biochem. 6: 2. doi: 10.1186/1471-2091-6-2.[CrossRef][Medline] Lin, J.C., Ho, W.H., Gurney, A., and Rosenthal, A. 2003. The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons. Nat. Neurosci. 6: 1270–1276.[CrossRef][Medline] Martin, M., Romero, X., de la Fuente, M.A., Tovar, V., Zapater, N., Esplugues, E., Pizcueta, P., Bosch, J., and Engel, P. 2001. CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: Adhesion is mediated by Ig-like domain 1. J. Immunol. 167: 3668–3676. Maslov, S. and Sneppen, K. 2002. Specificity and stability in topology of protein networks. Science 296: 910–913. Mavaddat, N., Mason, D.W., Atkinson, P.D., Evans, E.J., Gilbert, R.J., Stuart, D.I., Fennelly, J.A., Barclay, A.N., Davis, S.J., and Brown, M.H. 2000. Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J. Biol. Chem. 275: 28100–28109. Parrott, M.B. and Barry, M.A. 2001. Metabolic biotinylation of secreted and cell surface proteins from mammalian cells. Biochem. Biophys. Res. Commun. 281: 993–1000.[CrossRef][Medline] Pereira-Leal, J.B., Levy, E.D., Kamp, C., and Teichmann, S.A. 2007. Evolution of protein complexes by duplication of homomeric interactions. Genome Biol. 8: R51. doi: 10.1186/gb-2007-8-4-r51.[CrossRef][Medline] Polo-Parada, L., Bose, C.M., and Landmesser, L.T. 2001. Alterations in transmission, vesicle dynamics, and transmitter release machinery at NCAM-deficient neuromuscular junctions. Neuron 32: 815–828.[CrossRef][Medline] Quarles, R.H. 2002. Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration. Cell. Mol. Life Sci. 59: 1851–1871.[CrossRef][Medline] Reed, J., McNamee, C., Rackstraw, S., Jenkins, J., and Moss, D. 2004. Diglons are heterodimeric proteins composed of IgLON subunits, and Diglon-CO inhibits neurite outgrowth from cerebellar granule cells. J. Cell Sci. 117: 3961–3973. Rice, P., Longden, I., and Bleasby, A. 2000. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet. 16: 276–277.[CrossRef][Medline] Romero, X., Zapater, N., Calvo, M., Kalko, S.G., de la Fuente, M.A., Tovar, V., Ockeloen, C., Pizcueta, P., and Engel, P. 2005. CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse. J. Immunol. 174: 7033–7042. Rougon, G. and Hobert, O. 2003. New insights into the diversity and function of neuronal immunoglobulin superfamily molecules. Annu. Rev. Neurosci. 26: 207–238.[CrossRef][Medline] Schatz, P.J. 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: A 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology 11: 1138–1143.[Medline] Sidorenko, S.P. and Clark, E.A. 2003. The dual-function CD150 receptor subfamily: The viral attraction. Nat. Immunol. 4: 19–24.[CrossRef][Medline] Stagljar, I., Korostensky, C., Johnsson, N., and te Heesen, S. 1998. A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. Proc. Natl. Acad. Sci. 95: 5187–5192. Thisse, C. and Thisse, B. 1998. High resolution whole-mount in situ hybridization. In The Zebrafish Sci. Mon. Vol. 5, pp. 8–9. Thisse, B., Thisse, C., and Weston, J.A. 1995. Novel FGF receptor (Z-FGFR4) is dynamically expressed in mesoderm and neurectoderm during early zebrafish embryogenesis. Dev. Dyn. 203: 377–391.[Medline] Tomschy, A., Fauser, C., Landwehr, R., and Engel, J. 1996. Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains. EMBO J. 15: 3507–3514.[Medline] van der Merwe, P.A. and Barclay, A.N. 1994. Transient intercellular adhesion: The importance of weak protein–protein interactions. Trends Biochem. Sci. 19: 354–358.[CrossRef][Medline] van der Merwe, P.A. and Barclay, A.N. 1996. Analysis of cell-adhesion molecule interactions using surface plasmon resonance. Curr. Opin. Immunol. 8: 257–261.[CrossRef][Medline] van der Merwe, P.A., Barclay, A.N., Mason, D.W., Davies, E.A., Morgan, B.P., Tone, M., Krishnam, A.K., Ianelli, C., and Davis, S.J. 1994. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33: 10149–10160.[CrossRef][Medline] Voulgaraki, D., Mitnacht-Kraus, R., Letarte, M., Foster-Cuevas, M., Brown, M.H., and Barclay, A.N. 2005. Multivalent recombinant proteins for probing functions of leucocyte surface proteins such as the CD200 receptor. Immunology 115: 337–346.[CrossRef][Medline] Williams, A.F. and Barclay, A.N. 1988. The immunoglobulin superfamily—Domains for cell surface recognition. Annu. Rev. Immunol. 6: 381–405.[Medline] Wright, G.J., Puklavec, M.J., Willis, A.C., Hoek, R.M., Sedgwick, J.D., Brown, M.H., and Barclay, A.N. 2000. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13: 233–242.[CrossRef][Medline] Zhang, J., Lefebvre, J.L., Zhao, S., and Granato, M. 2004. Zebrafish unplugged reveals a role for muscle-specific kinase homologs in axonal pathway choice. Nat. Neurosci. 7: 1303–1309.[CrossRef][Medline]
Received September 25, 2007; accepted in revised format November 20, 2007. Related Article
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||